BioLife Solutions, Inc.

Thank you for standing by and welcome to the BioLife Solutions Q4 and full year 2020 earnings call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1 on your telephone. Please be advised that today's conference is being recorded.

Should you require any further assistance, please press star 0. I would now like to hand the conference over to your host, CFO, Roderick de Greef.

Sir, please go ahead. Thanks, Lateef. Good afternoon, everyone, and thank you for joining this call. Earlier today, we issued two press releases. The first was our announcement of the signing of a definitive merger agreement to acquire Global Cooling Inc., better known as Sterling Ultracold, a leading U.S.-based developer and manufacturer of ultra-low temperature freezers. The second press release detailed our Q4 and full year 2020 financial results and operational highlights. As a reminder during this call, we may make certain projections and other forward-looking statements regarding future events, for the future financial performance of the company or its acquisitions. These statements are subject to risks and uncertainties that may cause actual results to differ materially from expectations. For a detailed discussion of the risks and uncertainties that affect the company's business and that qualifies forward-looking statements, I refer you to our periodic and other public filings filed with the SEC. Company projections and forward-looking statements are based on factors that are subject to change and therefore these statements speak only as of the date they are given. The company assumes no obligation to update any projections or forward-looking statements except as required by law. During this call, we will speak to non-GAAP or adjusted results. Reconciliations of GAAP to non-GAAP or adjusted financial metrics are included in the press release we issued this afternoon. These non-GAAP or adjusted financial metrics should not be viewed as an alternative to GAAP. However, in light of our M&A activity, we believe that the use of non-GAAP or adjusted metrics provides investors with a clearer view of our current financial results when compared to prior periods. Now I'd like to turn the call over to Mike Rice, CEO of BioLife Solutions.